CRBP - Corbus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRBP is currently covered by 5 analysts with an average price target of $41.8. This is a potential upside of $131.29 (363.93%) from yesterday's end of day stock price of $9.01.

Corbus Pharmaceuticals's activity chart (see below) currently has 37 price targets and 50 ratings on display. The stock rating distribution of CRBP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.57% with an average time for these price targets to be met of 180.1 days.

Highest price target for CRBP is $53, Lowest price target is $30, average price target is $41.8.

Most recent stock forecast was given by from MIZUHO on 23-Jun-2026. First documented stock forecast 15-Nov-2016.

Currently out of the existing stock ratings of CRBP, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Sep-2024

$34

$25.26 (289.02%)

$44

24 days ago
(23-Jun-2026)

0/6 (0%)

$25.54 (301.89%)

Buy Since 10-May-2023

$52

$43.26 (494.97%)

$57

1 months ago
(17-Jun-2026)

5/14 (35.71%)

$43.95 (545.96%)

152

Buy Since 20-Sep-2024

$30

$21.26 (243.25%)

$38

1 months 20 days ago
(27-May-2026)

0/3 (0%)

$22.18 (283.63%)

Buy Since 07-Dec-2018

$53

$44.26 (506.41%)

8 months 4 days ago
(13-Nov-2025)

2/9 (22.22%)

$41.93 (378.77%)

837

Buy Since 07-May-2025

$40

$31.26 (357.67%)

$40

8 months 27 days ago
(20-Oct-2025)

0/3 (0%)

$21.72 (118.82%)

Show more analysts

Please expand the browser size to see the chart

What is CRBP (Corbus Pharmaceuticals) average time for price targets to be met?

On average it took 180.1 days on average for the stock forecasts to be realized with a an average price target met ratio 24.57

Which analyst has the current highest performing score on CRBP (Corbus Pharmaceuticals) with a proven track record?

BRIAN ABRAHAMS

Which analyst has the most public recommendations on CRBP (Corbus Pharmaceuticals)?

Brian Abrahams works at RBC and has 35 price targets and 25 ratings on CRBP

Which analyst is the currently most bullish on CRBP (Corbus Pharmaceuticals)?

Christopher Marai with highest potential upside - $951.29

Which analyst is the currently most reserved on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones with lowest potential downside - -$13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?